← Open Payments lookup

JAMES TANSINDA: Open Payments

NPI 1184690141 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,038 in 45 payments from 15 companies in 2025. Trend: 2023 $1,580 · 2024 $1,508 · 2025 $1,038

Food & beverage: $1,038
CompanyPaymentsAmount
Novo Nordisk Inc7$240
AstraZeneca Pharmaceuticals LP9$170
Sumitomo Pharma America, Inc.5$112
Exact Sciences Corporation4$91
GlaxoSmithKline, LLC.4$82
Bayer Healthcare Pharmaceuticals Inc.3$67
Boehringer Ingelheim Pharmaceuticals, Inc.3$63
Dexcom, Inc.2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Lundbeck LLC1$30

Products named: Ozempic, BREZTRI, GEMTESA, Cologuard Collection Kit, TRELEGY ELLIPTA, Kerendia, JARDIANCE, Dexcom G6 Transmitter.

Industry payments across MD — which companies pay providers there.